International Study Validates Veredus ‘Lab-on-Chip’ Multi-Drug Resistant TB Test

Researchers at hospitals and universities in five European countries and in Tanzania collaborated to evaluate the performance of VereMTB™ on 91 clinical isolates harbouring different resistance-conferring mutations. They reported a diagnostic accuracy of about 98 percent compared to sequencing and another assay, GenoType MTBDRplus from Hain Lifescience.

More information